Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2020

In 2020, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 6.89% of shares outstanding on 15 Jan 2020 to 11.25% on 31 Dec 2020, a change of +4.36 percentage points. The year's high was 16.39% on 13 Mar 2020 and its low 6.89% on 15 Jan 2020, averaging 12.55% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.65 days on 15 Dec 2020. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2020

2020 in figures

Start of year
6.89% (15 Jan 2020)
End of year
11.25% (31 Dec 2020)
Change
+4.36 pp
High
16.39% (13 Mar 2020)
Low
6.89% (15 Jan 2020)
Average
12.55%
Highest days to cover
20.65 (15 Dec 2020)
SEC filings marked
8

Every report in 2020

COLLEGIUM PHARMACEUTICAL, INC short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20206.89%6.29
31 Jan 20207.08%7.60
14 Feb 202012.88%2.92
28 Feb 202015.13%7.1010-K filed, results (8-K)
13 Mar 202016.39%8.33
31 Mar 202013.65%9.40
15 Apr 202014.06%11.71
30 Apr 202014.34%11.67
15 May 202013.37%10.0710-Q filed, results (8-K)
29 May 202012.90%12.79
15 Jun 202014.62%9.68
30 Jun 202013.64%12.74
15 Jul 202012.67%13.35
31 Jul 202012.10%15.82
14 Aug 202011.51%8.3210-Q filed, results (8-K)
31 Aug 202011.89%15.23
15 Sep 202012.23%13.47
30 Sep 202012.68%15.86
15 Oct 202012.85%15.97
30 Oct 202012.29%19.69
13 Nov 202013.71%15.3010-Q filed, results (8-K)
30 Nov 202011.67%20.56
15 Dec 202011.34%20.65
31 Dec 202011.25%15.67

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.